Measuring treatment response to advance precision medicine for multiple sclerosis

Abstract Objective To assess the independent contributions of clinical measures (relapses, Expanded Disability Status Scale [EDSS] scores, and neuroperformance measures) and nonclinical measures (new brain magnetic resonance imaging [MRI] activity and serum neurofilament light chain [sNfL] levels) f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Peter A. Calabresi, Ludwig Kappos, Gavin Giovannoni, Tatiana Plavina, Irene Koulinska, Michael R. Edwards, Bernd Kieseier, Carl deMoor, Elias S. Sotirchos, Elizabeth Fisher, Richard A. Rudick, Alfred Sandrock
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/fa352fd8745148f48a725597ae0f7a77
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!